Sterile pharmaceuticals manufacturer: no more bag side splits during multipacking

A manufacturer of sterile pharmaceuticals, including eye drops, packs its finished product in a bag-in-bag-in-bag system, and the sides of the bag were splitting during multipacking and transport between process stages. A dedicated NEX-BAG FARM formulation with increased film flexibility and softness, produced under a controlled pharma regime, eliminated the side splits.

01 Customer

A manufacturer of sterile pharmaceuticals in Poland, including eye drops. The finished product is packed in a multi-layer bag system: bag in a bag in a bag, with zero tolerance for microbiological contamination.

02 Challenge

The sides of the bag were splitting during multipacking and transport between process stages. In pharma, a split does not mean a complaint; it means the whole batch loses its sterility.

03 Solution

• Formulation: a dedicated NEX-BAG FARM formulation with increased film flexibility and softness.
• Production regime: a controlled pharma regime, meaning hair covers, documentation per batch and full repeatability.
• Quality: along the way, we closed out the customer’s historical quality issues with their previous supplier.

04 Results

• Splits: bag side splits eliminated.
• Quality: stable, documented quality batch after batch.
• Relationship: a strategic partnership instead of a tender-based relationship.

05 What this means for you

In GMP applications, film is part of the quality system, not a purchasing line item. If your supplier does not keep documentation per batch, in an audit it is you who answers for their process.